Previous 10 | Next 10 |
2023-10-13 17:30:08 ET More on Lululemon, Hubbell, Organon Nike Vs. Lululemon: One With A Moat, One With Growth Hubbell: Fairly Priced, Primed To Outpace Market Expectations Organon: The Federal Reserve Black Swan (Rating Upgrade) For further details see: ...
2023-10-04 11:45:54 ET Summary The stock of junk-rated Organon & Co. has lost more than 40% since my first article, largely due to interest rates continuing to rise. I take a close look at the company's debt and how I think the situation will evolve until 2028 - when OGN will ...
Her Promise Access Initiative helped prevent 57 million unplanned pregnancies putting the company approximately halfway to its goal of preventing 120 million unplanned pregnancies by 2030 Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, has been na...
On World Contraception Day, Organon Canada Declares Support for Universal Access to Contraception in Canada Canada NewsWire With nearly half of all pregnancies unintended in Canada , all sectors must work together to help tackle this public health issue KIRKLAND ...
2023-09-22 05:00:26 ET Worried that the Federal Reserve is driving our economy off a cliff? I’ve got two words for you: Drugs ‘n diapers . Actually, I forgot one. Dividends . These companies are about as recession-resistant as they come. Let’...
JADA Rapidly and Effectively Controlled Bleeding Due to PPH, 1 Reinforcing Pivotal Study Results 1 PPH is a Significant Cause of Maternal Morbidities in the U.S. 2,3,4,5 New Exploratory Post-Hoc Analysis Examined the Relationship Between Reported Severe Maternal Morbidity (SMM...
2023-09-10 02:23:12 ET Summary Organon & Co. stock is down 30% year-to-date and 40% below its 52-week highs. OGN offers a dividend yield of 5.8%, making it an attractive option for income-oriented investors. The company has a stable revenue base and potential for future di...
2023-09-09 07:20:00 ET On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. While the S&P 500 index is up by more than 17% year to date, that sector's stocks are down by nearly 3%. That trend, though, created some great opportunities...
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owens, M.D., as Head of Medical Affairs and Outcomes Research, strengthening the companyȁ...
VANCOUVER, BC / ACCESSWIRE / August 28, 2023 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to report profitable financial results from its operations for the second quarter ended June 30, 2023. Paddy Nicol, CEO of Orogen, commented: "We are happy to re...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 31, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce a new significant gold-silver discovery, called the Navidad vein system, on the Ermitaño Mine concessions in Sonora, Mexico where the Company holds a...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...